FindTrial
Sign In

Assessment of liver disease in HIV/HCV co-infected patients

Assessment of clinical profile and severity of liver disease in HIV/HCV co-infected patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/04/032529
Enrollment
30
Registered
2021-04-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A638- Other specified predominantly sexually transmitted diseases Health Condition 2: A638- Other specified predominantly sexually transmitted diseases

Interventions

None listed

Sponsors

Maulana Azad Medical College
Lead Sponsor
Dr Suresh Kumar
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: HIV/HCV co-infected patients of more than 18 years

Exclusion criteria

Exclusion criteria: HIV with Hepatitis B infection Portal HTN due to causes like hypercoaguable states Dementia,TBM MODS

Design outcomes

Primary

MeasureTime frame
To assess clinical profile of HIV/HCV co- infected patientsTimepoint: At the end of 6 weeks—

Secondary

MeasureTime frame
Severity of liver disease will be assessed by FIB4 score and CTP scoreTimepoint: At the end of 6weeks—

Countries

India

Contacts

Public ContactAarti Sah

Maulana Azad Medical College

drskumar31@yahoo.co.in9891158991

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026